hey, I am trying to add, too, but where is the line drawn if and when a government agency declares your company a candidate for a sickle cell drug, through the means of a public statement.
I don't see XKEM management denying this stmt made from that article.
I call that an 8-K event.
IMHO, there are some onfilled obligations here.
XKEM filed that 8-K from the Bristol Meyers Squib settlement money and how some of it was disbursed.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.